Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty's Government how many doses for a COVID-19 vaccine they have purchased from companies based in (1) the United States, (2) China, and (3) Russia; if none, whether they plan to purchase such vaccines from those countries; and if so, when.

The UK Government has agreements in the US with BioNTech/Pfizer for 30 million doses, Novavax for 60 million doses and Janssen for 30 million doses of their not-for-profit vaccine. We are taking a portfolio-based approach that monitors the landscape of coronavirus vaccine development, both here in the UK and internationally. Although we continue to investigate further potential vaccine candidates worldwide, we are currently not able to give any further information on these candidates owing to commercial sensitivity. We will, however, announce agreements with any other vaccine developers in due course.